Ocular gamut of neurofibromatosis type 1

Ocular gamut of neurofibromatosis type 1

Background: Neurofibromatosis type 1 (NF1) is a multi-system autosomal dominant disorder affecting 1 in 3000 individuals. The diagnostic criteria of NF1 includes ocular manifestations. Objective: To study the ophthalmic manifestations of neurofibromatosis type 1 and evaluate complications, if any. M...

Full description

Bibliographic Details
Main Authors:	Prathibha Shanthaveerappa, Nithisha Tegginamatha, Neethu Narayan Rao, Suyog Ajjampur Suryaprakash
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Kerala Journal of Ophthalmology
Subjects:	lisch nodules nf1 optic nerve glioma plexiform neurofibroma
Online Access:	http://www.kjophthal.com/article.asp?issn=0976-6677;year=2023;volume=35;issue=3;spage=284;epage=288;aulast=Shanthaveerappa

Similar Items

Lisch Nodules in Neurofibromatosis Type 1
by: J Gordon Millichap
Published: (1991-06-01)

Ojo con la neurofibromatosis
by: Alejandra Frontela, et al.
Published: (2022-07-01)

Extensive Plexiform Neurofibroma Presenting as Clitoromegaly in Neurofibromatosis Type 1
by: Özlem Nalbantoğlu, et al.
Published: (2021-08-01)

Cluster of Neurofibromatosis Cases in Remote Area of Northern Karnataka: A Case Series
by: Guruprasad K Y, et al.
Published: (2024-08-01)

Facial Plexiform Neurofibromatosis Type I
by: Bapan Devnath, et al.
Published: (2020-07-01)

Facial Plexiform Neurofibromatosis Type I
by: Bapan Devnath, et al.
Published: (2018-08-01)

Prevalence of neurofibromatosis type 1 in patients presenting with neurofibromas of the eyelid and orbit
by: Elisa Moya Kazmarek, et al.
Published: (2024-07-01)

Choroidal Hyperreflective Nodules Detected by Infrared Reflectance Images Are a Diagnostic Criterion for Neurofibromatosis Type 1 Patients Excluding Those with High Myopia
by: Marta Orejudo de Rivas, et al.
Published: (2023-04-01)

Dendritic Cell Neurofibroma with Pseudorosette: An Uncharted Entity at Unusual Sites: Two Case Reports with Literature Review
by: Pranita Mohanty, et al.
Published: (2024-07-01)

A Novel Treatment Modality for Malignant Peripheral Nerve Sheath Tumor Using a Dual-Effect Liposome to Combine Photodynamic Therapy and Chemotherapy
by: Chin-Tin Chen, et al.
Published: (2020-04-01)

Plexiform neurofibroma of the upper limb Neurofibroma plexiforme de membro superior
by: Kátia Torres Batista, et al.
Published: (2011-09-01)

Neurofibromatosis Type 1 in a Child with Plexiform Neurofibroma Pressing the Urinary System
by: XU Jianing, et al.
Published: (2023-04-01)

Congenital Craniofacial Plexiform Neurofibroma in Neurofibromatosis Type 1
by: Antonella Cacchione, et al.
Published: (2021-02-01)

NF-1 y neurofibromatosis hepática
by: Gaspar A. Motta-Ramírez, et al.
Published: (2024-10-01)

Efficacy and Safety of Trametinib in Neurofibromatosis Type 1-Associated Plexiform Neurofibroma and Low-Grade Glioma: A Systematic Review and Meta-Analysis
by: Dun Wang, et al.
Published: (2022-07-01)

Perinatal folate levels do not influence tumor latency or multiplicity in a model of NF1 associated plexiform-like neurofibromas
by: Kyle B. Williams, et al.
Published: (2023-10-01)

Giant gluteal and vesical plexiform neurofibromas in a patient with neurofibromatosis type 1: a case report
by: Imen Sassi, et al.
Published: (2024-01-01)

UN PEQUEÑO DOLOR CON UNA GRAN EXPLICACIÓN: NEUROFIBROMA PLEXIFORME CUTÁNEO
by: virginia González Hidalgo, et al.
Published: (2023-11-01)

Neurofibroma Plexiforme Vesical em Portador de Neurofibromatose: Relato de caso
by: Ana Carolina Bonini Domingos, et al.
Published: (2018-12-01)

Mandibular symmetry on posterior-anterior cephalograms of neurofibromatosis type 1 patients with facial plexiform neurofibroma
by: Friedrich, Reinhard E., et al.
Published: (2023-12-01)

Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Plexiform Neurofibroma Cells at Doses That Do Not Affect Patient-Matched Schwann Cells
by: Bashnona Attiah, et al.
Published: (2024-03-01)

Impact of neurofibromatosis type 1 with plexiform neurofibromas on the health-related quality of life and work productivity of adult patients and caregivers in the UK: a cross-sectional survey
by: Hyun Kyoo Yoo, et al.
Published: (2023-11-01)

Pharmacotherapy of plexiform neurofibromas in patients with neurofibromatosis type 1. Possible adverse events and their management
by: A. M. Pivovarova, et al.
Published: (2024-07-01)

Sleep-disordered breathing due to parapharyngeal space plexiform neurofibroma in neurofibromatosis-1: a case report and literature review
by: Manu Coimbatore Balakrishnan, et al.
Published: (2023-07-01)

DRI Triton SS-OCT applied to detect choroidal nodules in paediatric patients affected by NF1
by: Carlos Fresno Cañada, et al.
Published: (2024-04-01)

Progressive Mononeuropathy
by: J Gordon Millichap
Published: (1993-02-01)

Targeting the extracellular matrix for NF1-associated neurofibroma treatment
by: Chunhui Jiang
Published: (2024-06-01)

Whole-body MRI-based long-term evaluation of pediatric NF1 patients without initial tumor burden with evidence of newly developed peripheral nerve sheath tumors
by: Marie-Lena Schmalhofer, et al.
Published: (2024-11-01)

Plexiform neurofibromas of bilateral brachial and lumbosacral plexuses
by: S Sheetal, et al.
Published: (2022-01-01)

Abdominal plexiform neurofibroma. Case report
by: José Rolando Rodríguez Núñez, et al.
Published: (2025-01-01)

The role of multimodality imaging in diffuse pelvicoabdominal plexiform neurofibroma: A rare case report
by: Andi Ahmad Thoriq Pratama, et al.
Published: (2024-12-01)

The development of the PlexiQoL: A patient‐reported outcome measure for adults with neurofibromatosis type 1‐associated plexiform neurofibromas
by: Alice Heaney, et al.
Published: (2020-12-01)

Epidemiology and Outcomes of Neurofibromatosis Type 1 (NF-1): Multicenter Tertiary Experience
by: Almuqbil M, et al.
Published: (2024-03-01)

Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas
by: Rebecca M. Brown, et al.
Published: (2022-05-01)

The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands
by: Britt A. E. Dhaenens, et al.
Published: (2024-03-01)

Visual Deficits and Diagnostic and Therapeutic Strategies for Neurofibromatosis Type 1: Bridging Science and Patient-Centered Care
by: Kiyoharu J. Miyagishima, et al.
Published: (2024-05-01)

Partial Excision of Giant Plexiform Neurofibromatosis
by: P Kumar, et al.
Published: (2001-02-01)

Von Recklinghausen Neurofibromatosis
by: J Gordon Millichap
Published: (1988-12-01)

Forearm reconstruction with acellular dermal matrix after giant plexiform neurofibroma excision: case reports
by: Eduardo Madalosso Zanin, et al.
Published: (2022-03-01)

Discrimination of benign, atypical, and malignant peripheral nerve sheath tumours in neurofibromatosis type 1 – intraindividual comparison of positron emission computed tomography and diffusion-weighted magnetic resonance imaging
by: Inka Ristow, et al.
Published: (2024-12-01)